C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 110 filers reported holding C4 THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $5,321,000 | -39.5% | 705,736 | +94.7% | 0.57% | -54.2% |
| Q1 2022 | $8,795,000 | -31.5% | 362,528 | -9.0% | 1.24% | -11.9% |
| Q4 2021 | $12,831,000 | -24.8% | 398,469 | +4.4% | 1.41% | -1.5% |
| Q3 2021 | $17,058,000 | -13.1% | 381,774 | -26.4% | 1.43% | +8.0% |
| Q2 2021 | $19,624,000 | +6.7% | 518,611 | +4.3% | 1.33% | -5.9% |
| Q1 2021 | $18,389,000 | +25.9% | 497,136 | +12.0% | 1.41% | +8.8% |
| Q4 2020 | $14,601,000 | – | 443,824 | – | 1.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 481,094 | $15,939,000 | 8.67% |
| Bain Capital Life Sciences Investors, LLC | 1,642,209 | $54,406,000 | 3.42% |
| Darwin Global Management, Ltd. | 228,595 | $7,573,000 | 2.11% |
| Asymmetry Capital Management, L.P. | 139,343 | $4,616,000 | 2.10% |
| Cormorant Asset Management, LP | 2,490,065 | $80,021,000 | 1.90% |
| Logos Global Management LP | 477,928 | $15,834,000 | 1.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 443,824 | $14,601,000 | 1.30% |
| Soleus Capital Management, L.P. | 268,548 | $8,897,000 | 1.17% |
| P.A.W. CAPITAL CORP | 40,000 | $1,325,000 | 1.17% |
| RTW INVESTMENTS, LP | 2,149,228 | $68,679,000 | 1.15% |